Wentao Han | Medicine | Best Researcher Award

Posted on by sciencefather

Dr. Wentao Han | Medicine | Best Researcher Award

Dr. Wentao Han, Department of Ophthalmology, The Second Xiangya Hospital, Central South University, China

Wentao Han is a dedicated ophthalmology researcher specializing in diabetic eye complications, dry eye syndrome, and gene therapy. Currently pursuing his research at the Second Xiangya Hospital of Central South University, China, he has demonstrated a strong passion for advancing medical science through innovative studies. His contributions to ocular disease research, particularly in understanding the gut-eye axis and corneal wound healing, highlight his interdisciplinary approach. He has authored multiple high-impact journal articles and actively collaborates with global scholars. His research on machine learning applications in medical diagnosis showcases his forward-thinking vision in integrating AI with healthcare. Beyond academia, Wentao Han serves as a reviewer for prestigious journals, contributing to the integrity of scientific publications. His dedication to translational medicine and biomarker identification continues to shape new therapeutic strategies. His work aims to bridge laboratory findings with clinical applications, improving patient outcomes in ophthalmology and metabolic diseases.

Professional Profile 

Orcid

Suitability for the Research for Best Researcher Award – Wentao Han

Wentao Han demonstrates a strong research background in ophthalmology, particularly in the areas of diabetic eye complications, dry eye syndrome, and corneal wound healing. Currently pursuing research at the Second Xiangya Hospital of Central South University, he has made notable contributions to the field, with multiple high-impact publications in reputable journals. His expertise in the “gut metabolites–inflammation–eye axis” and gene therapy for Meibomian Gland Dysfunction (MGD) highlights his innovative approach to addressing critical challenges in ophthalmology.

His publication record is impressive, with multiple papers in Q1 and Q2 journals, including Pharmaceutics, The Ocular Surface, Acta Diabetologica, and Journal of Medical Internet Research. Notably, his work on machine learning prediction models, autophagy in retinal precursor cells, and the gut-eye axis showcases a multidisciplinary research approach. His role as an invited reviewer for respected journals further establishes his credibility in the academic community.

🎓 Education 

Wentao Han is currently pursuing advanced medical research at Central South University, Changsha, China, within the Department of Ophthalmology at the Second Xiangya Hospital. His academic journey reflects a deep commitment to ophthalmic research, focusing on diabetic retinopathy, ocular surface disorders, and corneal healing mechanisms. Through rigorous training and hands-on experience in clinical settings, he has honed his expertise in evidence-based medicine and translational research. His coursework and mentorship under leading ophthalmologists have allowed him to integrate molecular biology with patient-centered investigations. Additionally, he actively participates in research seminars, workshops, and scientific collaborations, reinforcing his knowledge of bioinformatics, gene therapy, and regenerative medicine. His strong foundation in medical sciences, combined with a keen interest in technological advancements, positions him as a promising young researcher in ophthalmology. His education has equipped him with critical skills to contribute to groundbreaking discoveries in the field of ocular diseases.

💼 Professional Experience 

As a researcher in ophthalmology at the Second Xiangya Hospital of Central South University, Wentao Han has contributed significantly to understanding diabetic eye complications and ocular disease mechanisms. His professional experience includes conducting clinical and preclinical studies on dry eye syndrome, corneal wound healing, and the gut-eye axis. He has extensive expertise in meta-analyses, molecular diagnostics, and the application of artificial intelligence in disease prediction. His work in identifying novel biomarkers for diabetic retinopathy has been widely recognized. Additionally, he collaborates with interdisciplinary teams, integrating bioinformatics and evidence-based medicine to develop innovative treatment approaches. Han’s active involvement in academic publishing and peer review for high-impact journals reflects his commitment to advancing medical knowledge. His current projects involve investigating gene therapy for meibomian gland dysfunction and corneal regeneration, with the aim of translating scientific discoveries into clinical applications that enhance patient care in ophthalmology.

🏅 Awards and Recognition 

Wentao Han has received multiple recognitions for his outstanding contributions to ophthalmic research. He has been an invited reviewer for prestigious journals such as Cell Death Discovery (IF = 7) and Acta Diabetologia (IF = 3.9), underscoring his expertise in diabetes-related ocular disorders. His research on gut metabolites’ role in eye diseases has been acknowledged at international conferences. Several of his published articles in Q1 journals have earned high citations, reflecting their impact on the scientific community. Han has also contributed to the development of machine learning prediction models for gestational diabetes mellitus, further showcasing his interdisciplinary proficiency. His involvement in groundbreaking studies on corneal wound healing has positioned him as a promising young researcher in ophthalmology. With a strong publication record, peer recognition, and contributions to medical advancements, Han continues to be a driving force in translational ophthalmic research and clinical innovation.

🌍 Research Skills On Medicine

Wentao Han possesses a diverse set of research skills that bridge molecular biology, clinical medicine, and artificial intelligence applications in ophthalmology. His expertise includes conducting systematic reviews, meta-analyses, and experimental research on diabetic retinopathy and dry eye syndrome. He is proficient in bioinformatics tools for gene analysis and biomarker identification, which he applies to precision medicine. Han is skilled in laboratory techniques such as immunohistochemistry, cell culture, and animal models for ocular disease studies. His ability to integrate AI and machine learning into medical research has led to innovative predictive models for disease diagnosis. Additionally, his work in gene therapy for corneal and meibomian gland dysfunction highlights his translational research capabilities. Han’s interdisciplinary approach allows him to explore novel therapeutic targets, making significant contributions to evidence-based medicine. His research aims to improve diagnostic accuracy and therapeutic interventions in ophthalmic and metabolic disorders.

📖 Publication Top Notes

  • Research Progress and Potential Applications of Spermidine in Ocular Diseases
  • Machine Learning Prediction Models for Gestational Diabetes Mellitus: Meta-analysis
    • Authors: Zheqing Zhang, Luqian Yang, Wentao Han, Yaoyu Wu, Linhui Zhang, Chun Gao, Kui Jiang, Yun Liu, Huiqun Wu
    • Citation: Journal of Medical Internet Research, 2022-03-16
    • Year: 2022
    • DOI: 10.2196/26634
  • Genome Analysis and Identification of Key Pathway in Visceral Adipose Tissue from Obesity-Related Diabetes
    • Authors: Wentao Han
    • Citation: Proceedings of the 2021 International Conference on Bioinformatics and Intelligent Computing, 2021-01-22
    • Year: 2021
    • DOI: 10.1145/3448748.3448757
  • Machine Learning Prediction Models for Gestational Diabetes Mellitus: Meta-analysis (Preprint)
    • Authors: Zheqing Zhang, Luqian Yang, Wentao Han, Yaoyu Wu, Linhui Zhang, Chun Gao, Kui Jiang, Yun Liu, Huiqun Wu
    • Citation: Preprint, 2020-12-19
    • Year: 2020
    • DOI: 10.2196/preprints.26634
  • Construction of a Knowledge Graph for Diabetes Complications from Expert-Reviewed Clinical Evidences
    • Authors: Wentao Han
    • Citation: Computer Assisted Surgery (Abingdon, England), 2020-11-25
    • Year: 2020
    • DOI: 10.1080/24699322.2020.1850866
    • PMID: 33275462
  • Association Between Retinol Binding Protein 4 and Diabetic Retinopathy Among Type 2 Diabetic Patients: A Meta-analysis
    • Authors: Wentao Han, Huagen Wei, Weizheng Kong, Jing Wang, Luqian Yang, Huiqun Wu
    • Citation: Acta Diabetologica, 2020-10
    • Year: 2020
    • DOI: 10.1007/s00592-020-01535-3

 

Sinenhlanhla Mthembu | Cardiovascular | Young Scientist Award

Posted on by sciencefather

Ms. Sinenhlanhla Mthembu | Cardiovascular | Young Scientist Award

👤 Ms. Sinenhlanhla Mthembu, North-West University, South Africa

Sinenhlanhla Xoliswa Happiness Mthembu is a PhD candidate in Biochemistry at North-West University, specializing in dyslipidemia-associated myocardial dysfunction and cardioprotective effects of natural compounds like aspalathin and sulforaphane. With a strong foundation in Biochemistry and Microbiology, Sinenhlanhla has contributed significantly to the understanding of mitochondrial bioenergetics, oxidative stress, and metabolic diseases, especially related to cardiovascular health. Her research and dedication have earned her several prestigious awards and recognitions, such as the IUBMB MilliporeSigma ENABLE-Africa Fellowship and the South African Women in Science Award. She is a member of the South African Society of Biochemistry and Molecular Biology and the South African Heart Association.

Professional Profile 

Scopus 

Orcid

Google Scholar

🌟  Suitability for the Award Research for Young Scientist Award

Sinenhlanhla Xoliswa Happiness Mthembu stands out as an ideal candidate for the Research for Young Scientist Award, owing to her impressive academic trajectory and pioneering contributions to the field of Biochemistry and Microbiology. Her current doctoral research on dyslipidemia-associated dysregulations and cardioprotective effects of aspalathin and sulforaphane, pursued at North-West University, is highly relevant and demonstrates a deep understanding of biochemical and mitochondrial bioenergetics. She has made significant strides in understanding the role of mitochondrial function in various diseases, especially in relation to cardiovascular and metabolic disorders, which showcases her scientific rigor.

In addition to her doctoral work, Mthembu has contributed extensively to scientific knowledge through numerous publications in renowned journals. Her research on the potential therapeutic roles of bioactive compounds like aspalathin and sulforaphane aligns with global health concerns, particularly in the areas of obesity, diabetes, and cardiovascular diseases. This breadth of work places her at the forefront of emerging research on metabolic diseases and therapeutic interventions.

🎓 Education 

Sinenhlanhla Mthembu’s educational journey reflects her dedication to advancing the field of Biochemistry. She completed her MSc in Biochemistry at the University of Zululand, where she explored the effect of Rooibos Polyphenols on mitochondrial function in skeletal muscles. Her undergraduate studies in Biochemistry and Microbiology laid a solid foundation for her research in molecular biology. She is currently pursuing a PhD at North-West University, investigating the cardioprotective effects of aspalathin and sulforaphane in the context of dyslipidemia. Her academic pursuits demonstrate a keen focus on cardiovascular health, oxidative stress, and mitochondrial bioenergetics, establishing her as a rising star in the scientific community.

💼  Professional Experience 

Sinenhlanhla Mthembu’s professional journey is marked by her current role as a PhD intern fellow at the South African Medical Research Council (SAMRC), where she investigates the impact of dyslipidemia and metabolic diseases on heart function. Her previous experience as a laboratory assistant and demonstrator at North-West University further enhanced her expertise in molecular biology, biochemistry, and scientific research techniques. She has worked extensively with techniques such as RT-qPCR, Western blot analysis, flow cytometry, and Seahorse XF technology. Throughout her career, Sinenhlanhla has contributed to the development of therapeutic approaches to tackle diabetes, obesity, and cardiovascular diseases.

🏅 Awards and Recognition 

Sinenhlanhla Mthembu’s excellence has been recognized with numerous awards and scholarships. She received the IUBMB MilliporeSigma ENABLE-Africa Fellowship in 2024, along with the South African Women in Science Award, which underscores her contributions to advancing women in science. Her outstanding presentation at the FEBS-IUBMB-ENABLE conference earned her the Outstanding Poster Award. Sinenhlanhla was also granted the SA Heart Congress Educational Grant to attend the 24th Annual SA Heart Congress. She has been awarded the SAMRC Scholarship Programme for both her PhD and MSc studies and has received the prestigious Top Achiever award from the Moses Kotane Institute and the University of Zululand.

🌍  Research Skills On Cardiovascular

Sinenhlanhla Mthembu possesses an array of advanced research skills, with a strong focus on Biochemistry and Molecular Biology. Her expertise includes Metagenomics sequencing, RT-qPCR, Western blot analysis, and flow cytometry. She has experience in scientific peer review and writing, as well as cell culture techniques. Sinenhlanhla is proficient in utilizing Seahorse XF technology and ELISA assays to evaluate metabolic changes at the cellular level. Her research focuses on dyslipidemia, mitochondrial dysfunction, oxidative stress, and the role of natural compounds like aspalathin and sulforaphane in combating metabolic diseases, particularly cardiovascular complications.

📖 Publication Top Notes

  • Rutin ameliorates inflammation and improves metabolic function: A comprehensive analysis of scientific literature
    Authors: N Muvhulawa, PV Dludla, K Ziqubu, SXH Mthembu, F Mthiyane, …
    Citation: Pharmacological research 178, 106163
    Year: 2022
  • Detrimental effects of lipid peroxidation in type 2 diabetes: Exploring the neutralizing influence of antioxidants
    Authors: SC Shabalala, R Johnson, AK Basson, K Ziqubu, N Hlengwa, …
    Citation: Antioxidants 11 (10), 2071
    Year: 2022
  • A Review on the Antidiabetic Properties of Moringa oleifera Extracts: Focusing on Oxidative Stress and Inflammation as Main Therapeutic Targets
    Authors: FT Mthiyane, PV Dludla, K Ziqubu, SXH Mthembu, N Muvhulawa, …
    Citation: Frontiers in Pharmacology 13, 940572
    Year: 2022
  • An insight into brown/beige adipose tissue whitening, a metabolic complication of obesity with the multifactorial origin
    Authors: K Ziqubu, PV Dludla, SXH Mthembu, BB Nkambule, SE Mabhida, BU Jack, …
    Citation: Frontiers in Endocrinology 14, 1114767
    Year: 2023
  • Anti-obesity effects of metformin: a scoping review evaluating the feasibility of brown adipose tissue as a therapeutic target
    Authors: K Ziqubu, SE Mazibuko-Mbeje, SXH Mthembu, SE Mabhida, BU Jack, …
    Citation: International Journal of Molecular Sciences 24 (3), 2227
    Year: 2023
  • Impact of physical exercise and caloric restriction in patients with type 2 diabetes: Skeletal muscle insulin resistance and mitochondrial dysfunction as ideal therapeutic targets
    Authors: SXH Mthembu, SE Mazibuko-Mbeje, K Ziqubu, TA Nyawo, N Obonye, …
    Citation: Life Sciences 297, 120467
    Year: 2022
  • Physical exercise potentially targets epicardial adipose tissue to reduce cardiovascular disease risk in patients with metabolic diseases: Oxidative stress and inflammation
    Authors: TA Nyawo, C Pheiffer, SE Mazibuko-Mbeje, SXH Mthembu, …
    Citation: Antioxidants 10 (11), 1758
    Year: 2021
  • Impact of isoorientin on metabolic activity and lipid accumulation in differentiated adipocytes
    Authors: K Ziqubu, CJF Muller, PV Dludla, SXH Mthembu, N Obonye, J Louw, …
    Citation: Molecules 25 (8), 1773
    Year: 2020
  • A systematic review exploring the significance of measuring epicardial fat thickness in correlation to B-type natriuretic peptide levels as prognostic and diagnostic markers in
    Authors: TA Nyawo, PV Dludla, SE Mazibuko-Mbeje, SXH Mthembu, …
    Citation: Heart Failure Reviews, 1-11
    Year: 2022
  • Rooibos flavonoids, aspalathin, isoorientin, and orientin ameliorate antimycin A-induced mitochondrial dysfunction by improving mitochondrial bioenergetics in cultured skeletal
    Authors: SXH Mthembu, CJF Muller, PV Dludla, E Madoroba, AP Kappo, …
    Citation: Molecules 26 (20), 6289
    Year: 2021

 

Alberto Esteban Fernández | Miocardiopatías | Best Researcher Award

Posted on by sciencefather

Assoc. Prof. Dr. Alberto Esteban Fernández | Miocardiopatías | Best Researcher Award

👤 Assoc. Prof. Dr. Alberto Esteban Fernández, Hospital Universitario Severo Ochoa, Spain

Alberto Esteban Fernández, born in Valladolid on July 4, 1984, is a distinguished cardiologist and expert in heart failure, particularly in the field of myocardial diseases. With a career spanning both clinical and academic settings, Dr. Fernández has made significant contributions to research and clinical practice in cardiology. He currently holds positions as a specialist in heart failure at the Hospital Universitario Severo Ochoa and as a tutor for cardiology residents. With extensive international experience, he has collaborated with the European Society of Cardiology and several esteemed research centers. Dr. Fernández is dedicated to advancing the treatment of dilated cardiomyopathy and heart failure through innovative research and clinical care. He also plays an active role in several medical committees and ethical boards. In addition to his clinical expertise, he is a passionate educator, mentoring the next generation of cardiologists.

Professional Profile

Scopus

Orcid

Google Scholar

🌟 Suitability for the “Research for Best Researcher Award”

Alberto Esteban Fernández is an exceptional candidate for the “Research for Best Researcher Award” due to his extensive background in cardiology, particularly in heart failure, and his remarkable contributions to both clinical practice and research. He holds a Doctorate in Medicine from the University of Navarra, where his thesis on cardiac magnetic resonance imaging in ischemic heart disease showcased his expertise and commitment to advancing the field. Furthermore, his postdoctoral experience, including a research fellowship at the BHF Cardiovascular Research Centre, demonstrates his capacity to engage in high-level scientific inquiry.

His qualifications, including multiple master’s degrees, certifications in cardiology, and advanced heart failure, reflect his continuous pursuit of knowledge and professional growth. Notably, his role as a leading specialist in advanced heart failure and his leadership in cardiology departments at prominent hospitals, such as the Hospital Universitario Severo Ochoa and the Hospital Universitario de Móstoles, underline his ability to merge clinical excellence with research, creating impactful contributions to healthcare.

🎓 Education

Dr. Alberto Esteban Fernández’s academic journey is marked by a series of prestigious qualifications. He is currently pursuing a Master’s in Statistics in Health Sciences at the University of Barcelona. He earned an Expert University Degree in Family Cardiopathies from the University Francisco de Vitoria in 2021. Dr. Fernández also holds multiple advanced certifications, including the European Society of Cardiology’s HFA Certification in Heart Failure (2020), and a Doctorate in Medicine from the University of Navarra (2019), where he received the Outstanding Cum Laude distinction. His doctoral thesis focused on the use of cardiac magnetic resonance imaging in detecting myocardial ischemia. Furthermore, he completed a Master’s in Health Research Methodology at the University of Salamanca and postgraduate studies in various cardiology specialties. His academic credentials are complemented by numerous certifications in advanced cardiac care and specialized heart failure treatment, demonstrating his commitment to excellence in the medical field.

 💼  Professional Experience

Dr. Alberto Esteban Fernández has an extensive professional background, primarily in cardiology with a focus on heart failure. He is currently a Specialist at the Hospital Universitario Severo Ochoa, where he manages the heart failure unit. He has previously held key roles at the Hospital Universitario de Móstoles, where he led the heart failure unit, and at various other prestigious institutions, including the Hospital Clínico Universitario San Carlos in Madrid. Additionally, Dr. Fernández has served as a scientific editor for the Spanish Society of Cardiology’s blog and Cardioteca, contributing to the dissemination of cutting-edge research. His international experience includes fellowships at the Golden Jubilee National Hospital and the University of Glasgow, where he advanced his expertise in heart failure and transplantation. As a clinical and academic leader, Dr. Fernández is also involved in several cardiology committees and actively contributes to the medical community through teaching and mentorship.

🏅 Awards and Recognition

Dr. Alberto Esteban Fernández has received numerous accolades throughout his career, reflecting his contributions to the field of cardiology. He holds the prestigious Doctorate in Medicine from the University of Navarra, awarded with the highest distinction, Cum Laude. His work in heart failure and myocardial diseases has been recognized by the European Society of Cardiology, where he holds several certifications. Dr. Fernández was also appointed to the Heart Failure Association of the European Society of Cardiology’s committees, where he continues to influence the direction of clinical practice. He has been recognized as a leader in his field by his peers and is a key figure in Spanish cardiology. His efforts in advancing research, patient care, and medical education have earned him a reputation as one of the foremost experts in heart failure treatment and management.

🌍 Research Skills On Miocardiopatías

Dr. Alberto Esteban Fernández is a highly skilled researcher with a focus on heart failure, myocardial diseases, and advanced cardiology techniques. His research expertise spans cardiac magnetic resonance imaging, risk stratification in heart failure, and the genetic components of cardiomyopathies. Dr. Fernández’s doctoral thesis on cardiac stress imaging for myocardial ischemia detection contributed significantly to clinical practice and research. He is adept at designing and executing clinical trials and observational studies, particularly in the context of heart failure and cardiomyopathy. Dr. Fernández has published numerous articles in high-impact journals and has presented his research at international conferences, where his work is widely recognized. His research is supported by his clinical experience, ensuring that his studies are grounded in real-world applications. Additionally, he collaborates with various research institutions and participates in international studies, contributing to the advancement of cardiology research.

📖 Publication Top Notes

  • Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation
    Authors: N Calvo, N Salterain, H Arguedas, A Macias, A Esteban, …
    Citation: Ep Europace 17 (10), 1533-1540
    Year: 2015
  • In-hospital mortality and readmissions for heart failure in Spain. A Study of Index Episodes and 30-Day and 1-year Cardiac Readmissions
    Authors: PM Santos, RB Freire, AE Fernández, JLB Sobrino, CF Pérez, …
    Citation: Revista Española de Cardiología (English Edition) 72 (12), 998-1004
    Year: 2019
  • Sacubitril/valsartan in daily clinical practice: data from a prospective registry
    Authors: L Vicent, A Esteban-Fernández, M Gómez-Bueno, J De-Juan, …
    Citation: Journal of Cardiovascular Pharmacology 73 (2), 118-124
    Year: 2019
  • Frailty and prognosis of older patients with chronic heart failure
    Authors: C Jiménez-Méndez, P Díez-Villanueva, C Bonanad, C Ortiz-Cortés, …
    Citation: Revista Española de Cardiología (English Edition) 75 (12), 1011-1019
    Year: 2022
  • Consensus document and recommendations on palliative care in heart failure of the Heart Failure and Geriatric Cardiology Working Groups of the Spanish Society of Cardiology
    Authors: JMG Pinilla, P Díez-Villanueva, RB Freire, F Formiga, MC Marcos, …
    Citation: Revista Española de Cardiología (English Edition) 73 (1), 69-77
    Year: 2020
  • Safety of sacubitril/valsartan initiated during hospitalization: data from a non‐selected cohort
    Authors: JC López‐Azor, L Vicent, MJ Valero‐Masa, A Esteban‐Fernández, …
    Citation: ESC Heart Failure 6 (6), 1161-1166
    Year: 2019
  • Sex influence on the efficacy and safety of sacubitril/valsartan
    Authors: L Vicent, A Ayesta, A Esteban-Fernández, M Gómez-Bueno, J De-Juan, …
    Citation: Cardiology 142 (2), 73-78
    Year: 2019
  • Sacubitril/Valsartan is useful and safe in elderly people with heart failure and reduced ejection fraction. Data from a real-word cohort
    Authors: A Esteban-Fernández, P Díez-Villanueva, L Vicent, R Bover, …
    Citation: Revista Espanola de Geriatria y Gerontologia 55 (2), 65-69
    Year: 2020
  • Mortalidad hospitalaria y reingresos por insuficiencia cardiaca en España. Un estudio de los episodios índice y los reingresos por causas cardiacas a los 30 días y al año
    Authors: PM Santos, RB Freire, AE Fernández, JLB Sobrino, CF Pérez, …
    Citation: Revista Española de Cardiología 72 (12), 998-1004
    Year: 2019
  • Clinical profile of a nonselected population treated with sacubitril/valsartan is different from PARADIGM-HF trial
    Authors: L Vicent, A Esteban-Fernandez, M Gomez-Bueno, J De-Juan, …
    Citation: Journal of Cardiovascular Pharmacology 72 (2), 112-116
    Year: 2018

Ron Waksman | Cardiology | Best Researcher Award

Posted on by sciencefather

Dr. Ron Waksman | Cardiology | Best Researcher Award

👨‍⚕️Dr. Ron Waksman, MedStar Health, United States

Dr. Ron Waksman is a prominent figure in the field of cardiology, currently serving as the Director of Cardiovascular Research and Advanced Education at MedStar Heart & Vascular Institute. With an academic background spanning multiple continents, he has established himself as a leading expert in interventional cardiology and cardiovascular research. His vast professional journey reflects a dedication to advancing cardiovascular medicine and educating future generations of physicians.

Author Professional Profile

Scopus

Google Scholar

Evaluation of Ron Waksman, MD, FACS for the Best Researcher Award

Summary of Suitability

Dr. Ron Waksman is an outstanding candidate for the Best Researcher Award. His unparalleled contributions to cardiovascular medicine through research, clinical innovation, and academic leadership are well-aligned with the criteria for this recognition. His legacy of impactful work and dedication to advancing the field make him a deserving recipient of this prestigious award.

EARLY ACADEMIC PURSUITS 🎓

Dr. Waksman’s academic journey began at the Hebrew University in Jerusalem, where he earned his Bachelor of Science in Statistics, Economics, and Business Administration in 1975. His medical education continued at Ben Gurion University in Beer-Sheva, Israel, where he graduated with a Medical Degree (MD) in 1981. His commitment to further specialization led him to multiple prestigious institutions for residency and fellowships, including Emory University and Hadassah University Hospital.

PROFESSIONAL ENDEAVORS 💼

Dr. Waksman’s professional career includes significant roles in both academic and clinical settings. He has been a clinical professor of medicine at Georgetown University since 2001 and has served as the Associate Director of the Division of Cardiology at MedStar Washington Hospital Center. His leadership in cardiovascular research and innovation is showcased through his role in pioneering experimental angioplasty and advancing new technologies in cardiovascular care.

ACADEMIC CITES 🔬

Dr. Waksman’s impact on cardiology extends beyond clinical practice, with numerous publications in top-tier journals. He has been recognized for his contributions to advancing interventional cardiology, particularly in areas of experimental angioplasty, vascular brachytherapy, and innovative cardiovascular therapies. He also serves on several editorial boards and holds the position of Editor-in-Chief for Cardiovascular Revascularization Medicine.

CONTRIBUTIONS AND RESEARCH FOCUS ON Cardiology 🔍

Dr. Waksman’s research has contributed to many groundbreaking studies in cardiovascular medicine. His role as a principal investigator in numerous pivotal clinical trials, such as IRIS and WRIST, has helped shape the landscape of interventional cardiology. His research interests include enhancing the outcomes of angioplasty, improving cardiovascular device technologies, and exploring new therapies for vascular diseases.

IMPACT AND INFLUENCE 🌍

Dr. Waksman’s influence is felt across the global cardiology community. Through his extensive clinical experience and research contributions, he has become a mentor and educator, shaping the future of interventional cardiology. His work has had a lasting impact on medical practice and patient outcomes, especially in the areas of heart disease and vascular interventions.

LEGACY AND FUTURE CONTRIBUTIONS ⏳

Dr. Waksman’s legacy will be defined by his contributions to cardiovascular research, education, and innovation. His work continues to inspire the next generation of cardiologists, and his future contributions will likely focus on advancing minimally invasive techniques and developing novel therapies for cardiovascular diseases. His leadership in clinical trials will ensure that his influence remains strong in shaping the future of interventional cardiology.

CONCLUSION 🏁

Dr. Ron Waksman stands as a leader in the field of cardiology, with a distinguished career spanning education, research, and clinical practice. His dedication to improving patient care, advancing medical knowledge, and educating future cardiologists ensures his lasting impact on the field. As he continues his work, Dr. Waksman’s contributions will no doubt shape the future of cardiovascular medicine for years to come.

NOTABLE TOP PUBLICATIONS 📖

Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy
  • Authors: EP McFadden, E Stabile, E Regar, E Cheneau, ATL Ong, T Kinnaird, …
    Journal: The Lancet
    Year: 2004

Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate

  • Authors: L Bonello, US Tantry, R Marcucci, R Blindt, DJ Angiolillo, R Becker, …
    Journal: Journal of the American College of Cardiology
    Year: 2010
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants
  • Authors: Schwartz Stephen M, Siscovick David S, …
    Journal: Nature Genetics
    Year: 2009
Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial
  • Authors: R Erbel, C Di Mario, J Bartunek, J Bonnier, B de Bruyne, FR Eberli, P Erne, …
    Journal: The Lancet
    Year: 2007
Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding
  • Authors: US Tantry, L Bonello, D Aradi, MJ Price, YH Jeong, DJ Angiolillo, …
    Journal: Journal of the American College of Cardiology
    Year: 2013
Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents
  • Authors: PK Kuchulakanti, WW Chu, R Torguson, P Ohlmann, SW Rha, LC Clavijo, …
    Journal: Circulation
    Year: 2006
The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox?
  • Authors: L Gruberg, NJ Weissman, R Waksman, S Fuchs, R Deible, EE Pinnow, …
    Journal: Journal of the American College of Cardiology
    Year: 2002
Transcatheter aortic valve implantation in failed bioprosthetic surgical valves
  • Authors: D Dvir, JG Webb, S Bleiziffer, M Pasic, R Waksman, S Kodali, M Barbanti, …
    Journal: JAMA
    Year: 2014
Intracoronary γ-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis
  • Authors: R Waksman, RL White, RC Chan, BG Bass, L Geirlach, GS Mintz, …
    Journal: Circulation
    Year: 2000
Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies
  • Authors: AJ Kirtane, A Gupta, S Iyengar, JW Moses, MB Leon, R Applegate, …
    Journal: Circulation
    Year: 2009

Jonathan Golledge | Medicine and Dentistry | Best Researcher Award

Posted on by sciencefather

Prof Dr. Jonathan Golledge | Medicine and Dentistry | Best Researcher Award

James Cook University | Australia

Author Profile

Early Academic Pursuits

Jonathan Golledge began his academic journey at Cambridge University, UK, where he earned his BA in Medical Sciences in 1987. He continued at Cambridge, obtaining his MB BChir in Medicine in 1989, followed by an MChir in Surgery in 1997. His academic prowess was evident early on, with honors and distinctions marking his educational achievements.

Professional Endeavors

His professional journey encompasses a wealth of experiences across various institutions and countries. From his junior surgical posts in Cambridge and London to his tenure as a Lecturer in Surgery at Charing Cross and Westminster Medical School, UK, his career has been marked by a dedication to surgical practice and academic excellence.

Contributions and Research Focus

A significant aspect of His career lies in his contributions to vascular surgery and related research. His work spans from basic laboratory investigations to clinical trials, focusing on peripheral vascular disease and related pathologies. His research efforts have led to numerous publications, collaborations, and accolades, establishing him as a prominent figure in the field.

Accolades and Recognition

Hiscontributions have been widely recognized through national and international awards. These include prestigious scholarships, fellowships, and prizes from esteemed organizations such as the Royal Colleges of Surgeons, the European Society for Vascular Surgery, and various medical foundations. His work has consistently garnered praise and acknowledgment within the medical community.

Impact and Influence

Through his roles as a professor, director, and fellow, Golledge has had a profound impact on vascular surgery, education, and research. His leadership in establishing research centers, mentoring students and colleagues, and collaborating on groundbreaking studies has contributed significantly to the advancement of vascular medicine.

Legacy and Future Contributions

His legacy extends beyond his individual achievements to the broader landscape of vascular surgery and academia. His ongoing commitment to research, education, and clinical practice ensures a lasting impact on the field, with anticipated future contributions that will continue to shape the future of vascular medicine.

Citations

A total of 28230 citations for His publications, demonstrating the impact and recognition of His research within the academic community.

  • Citations          28230
  • h-index            85
  • i10-index         419

Notable Publications 

Editor's choice–European Society for Vascular Surgery (ESVS) 2019 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms
A Wanhainen, F Verzini, I Van Herzeele, E Allaire, M Bown, T Cohnert, ...
(1),2019

Abdominal aortic aneurysm: pathogenesis and implications for management
J Golledge, J Muller, A Daugherty, P Norman
(12), 2006

Acute aortic dissection
J Golledge, KA Eagle
(9632),2008

The symptomatic carotid plaque
J Golledge, RM Greenhalgh, AH Davies
(3), 2000

Abdominal aortic aneurysm: update on pathogenesis and medical treatments
J Golledge
(4), 2019

Osteoprotegerin, vascular calcification and atherosclerosis
A Van Campenhout, J Golledge
(2), 2009

Biomechanical characteristics of peripheral diabetic neuropathy: A systematic review and meta-analysis of findings from the gait cycle, muscle activity and dynamic barefoot …
M Fernando, R Crowther, P Lazzarini, K Sangla, M Cunningham, ...
(8), 2013

Guideline for the diagnosis and management of hypertension in adults—2016
GM Gabb, AA Mangoni, CS Anderson, D Cowley, JS Dowden, J Golledge, ...
(2), 2016

Atherosclerosis and abdominal aortic aneurysm: cause, response, or common risk factors?
J Golledge, PE Norman
(6), 2010

Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis
J Golledge, M McCann, S Mangan, A Lam, M Karan
(7), 2004